Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing study of etoposide capsule plus cisplatin in cervical cancer
jRCT2080221037
- Sponsor
- Nippon Kayaku Co., Ltd.
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of etoposide and cisplatin in Cervical Cancer (CC) (2 arms), sponsored by Nippon Kayaku Co., Ltd.
02
Drugs
etoposidecisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on jRCT2080221037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221037.